Cognition-Enhancing Drugs

Abstract

New drugs that enhance cognition in cognitively healthy individuals present difficult public policy challenges. While their use is not inherently unethical, steps must be taken to ensure that they are safe, that they are widely available to promote equality of opportunity, and that individuals are free to decide whether or not to use them.

Keywords

Cognition-Enhancing Drugs

Publication Date

2004

Document Type

Article

Place of Original Publication

Milbank Quarterly

Publication Information

82 Milbank Quarterly 483 (2004)

This document is currently not available here.

Share

COinS Maxwell J. Mehlman Faculty Bio